Diebold Nixdorf, Incorporated (DBD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Diebold Nixdorf, Incorporated (DBD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Diebold Nixdorf, Incorporated (DBD) Q1 2026 Earnings Call Transcript
Diebold Nixdorf, Incorporated (DBD) concluded the recent trading session at $85.64, signifying a +1.35% move from its prior day's close.
Diebold Nixdorf (NYSE: DBD - Get Free Report) is anticipated to issue its Q1 2026 results before the market opens on Thursday, April 30th. Analysts expect the company to announce earnings of $0.61 per share and revenue of $846.2330 million for the quarter. Diebold Nixdorf has set its FY 2026 guidance at 5.250-5.750 EPS. Parties may
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Diebold Nixdorf, Incorporated (DBD) concluded the recent trading session at $88.77, signifying a +2.86% move from its prior day's close.
Diebold Nixdorf has delivered strong returns post-bankruptcy, driven by its global ATM leadership and shift toward high-margin, recurring services revenue. DBD's growth thesis centers on banking services and self-checkout (SCO) expansion, particularly in North America, with recurring services now 70% of segment revenue. Management guides for double-digit adjusted EBITDA growth by 2027, 60% FCF conversion, and a disciplined opex reduction plan supporting margin expansion.
In the most recent trading session, Diebold Nixdorf, Incorporated (DBD) closed at $86.3, indicating a +1.74% shift from the previous trading day.
Zacks.com users have recently been watching Diebold Nixdorf, Incorporated (DBD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Diebold Nixdorf, Incorporated (DBD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Diebold Nixdorf remains a Buy as operational momentum, profitability, and free cash flow continue to strengthen, with FY 2026 guidance improving. DBD's addition to the S&P SmallCap 600 has driven near-term buying pressure, but the fundamental investment case is underpinned by rising EPS and margin expansion. Revenue for FY 2025 grew 1.5% to $3.80 billion, EBITDA margin improved to 12.7%, and free cash flow surged 120%, with a robust $300 million in buyback authorizations last year.